Middleton & CO Inc Abbott Laboratories Transaction History

Middleton & CO Inc

$898 Million
Q3 2024

A detailed history of Middleton & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Middleton & CO Inc holds 34,611 shares of ABT stock, worth $3.95 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

34,611

Previous 35,831 3.4%

Holding current value

$3.95 Million

Previous $3.72 Million 5.99%

% of portfolio

0.44%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$100.07 - $118.13 $122,085 - $144,118	-1,220 Reduced 3.4%	34,611 $3.95 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $150,087 - $167,535	-1,490 Reduced 3.99%	35,831 $3.72 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $127,590 - $140,918	-1,165 Reduced 3.03%	37,321 $4.24 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $23,900 - $29,256	-265 Reduced 0.68%	38,486 $4.24 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $93,619 - $112,327	-980 Reduced 2.47%	38,751 $3.75 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $51,498 - $57,380	-511 Reduced 1.27%	39,731 $4.33 Million
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $27,120 - $31,922	280 Added 0.7%	40,242 $4.07 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $85,554 - $100,368	-900 Reduced 2.2%	39,962 $4.39 Million
Q3 2022 Nov 02, 2022	SELL	$96.76 - $112.03 $1.46 Million - $1.69 Million	-15,047 Reduced 26.91%	40,862 $3.95 Million
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $125,035 - $151,128	-1,225 Reduced 2.14%	55,909 $6.07 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $28,882 - $35,365	-250 Reduced 0.44%	57,134 $8.04 Million
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $98,111 - $108,539	-841 Reduced 1.44%	57,384 $6.78 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $44,220 - $52,053	418 Added 0.72%	58,225 $6.75 Million
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $61,276 - $72,193	-563 Reduced 0.96%	57,962 $6.96 Million
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $16,870 - $19,875	-155 Reduced 0.27%	57,807 $6.93 Million
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $191,625 - $208,816	-1,825 Reduced 3.02%	58,525 $6.41 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $97,230 - $118,078	-1,061 Reduced 1.73%	60,350 $6.57 Million
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $46,248 - $59,192	604 Added 0.99%	61,411 $5.62 Million
Q1 2020 Apr 22, 2020	BUY	$62.82 - $91.86 $53,145 - $77,713	846 Added 1.41%	60,807 $4.8 Million
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $87,695 - $97,625	1,117 Added 1.9%	59,961 $5.21 Million
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $18,986 - $20,587	-232 Reduced 0.39%	58,844 $4.92 Million
Q2 2019 Jul 25, 2019	SELL	$72.88 - $85.0 $81,261 - $94,775	-1,115 Reduced 1.85%	59,076 $4.97 Million
Q1 2019 Apr 25, 2019	BUY	$66.22 - $80.06 $89,529 - $108,241	1,352 Added 2.3%	60,191 $4.81 Million
Q4 2018 Feb 01, 2019	BUY	$65.56 - $74.27 $822,646 - $931,939	12,548 Added 27.11%	58,839 $4.26 Million
Q3 2018 Oct 25, 2018	SELL	$60.81 - $73.36 $31,742 - $38,293	-522 Reduced 1.12%	46,291 $3.4 Million
Q2 2018 Jul 26, 2018	BUY	$57.57 - $63.54 $20,322 - $22,429	353 Added 0.76%	46,813 $2.86 Million
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $35,506 - $40,144	631 Added 1.38%	46,460 $2.78 Million
Q4 2017 Jan 25, 2018	SELL	$53.68 - $57.47 $18,788 - $20,114	-350 Reduced 0.76%	45,829 $2.62 Million
Q3 2017 Oct 31, 2017	BUY	$48.06 - $53.64 $2.22 Million - $2.48 Million	46,179	46,179 $2.46 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.

Account